These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21815361)

  • 1. Use of machine learning methods for prediction of acute toxicity in organs at risk following prostate radiotherapy.
    Pella A; Cambria R; Riboldi M; Jereczek-Fossa BA; Fodor C; Zerini D; Torshabi AE; Cattani F; Garibaldi C; Pedroli G; Baroni G; Orecchia R
    Med Phys; 2011 Jun; 38(6):2859-67. PubMed ID: 21815361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
    Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical-learning strategies generate only modestly performing predictive models for urinary symptoms following external beam radiotherapy of the prostate: A comparison of conventional and machine-learning methods.
    Yahya N; Ebert MA; Bulsara M; House MJ; Kennedy A; Joseph DJ; Denham JW
    Med Phys; 2016 May; 43(5):2040. PubMed ID: 27147316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An artificial neural network for predicting the incidence of radiation pneumonitis.
    Su M; Miften M; Whiddon C; Sun X; Light K; Marks L
    Med Phys; 2005 Feb; 32(2):318-25. PubMed ID: 15789575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late rectal bleeding after 3D-CRT for prostate cancer: development of a neural-network-based predictive model.
    Tomatis S; Rancati T; Fiorino C; Vavassori V; Fellin G; Cagna E; Mauro FA; Girelli G; Monti A; Baccolini M; Naldi G; Bianchi C; Menegotti L; Pasquino M; Stasi M; Valdagni R
    Phys Med Biol; 2012 Mar; 57(5):1399-412. PubMed ID: 22349550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of machine learning methods for prediction of acute and late rectal toxicity due to curative prostate radiotherapy.
    Ozkan EE; Serel TA; Soyupek AS; Kaymak ZA
    Radiat Prot Dosimetry; 2024 Aug; 200(13):1244-1250. PubMed ID: 38932433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On feature extraction and classification in prostate cancer radiotherapy using tensor decompositions.
    Fargeas A; Albera L; Kachenoura A; Dréan G; Ospina JD; Coloigner J; Lafond C; Delobel JB; De Crevoisier R; Acosta O
    Med Eng Phys; 2015 Jan; 37(1):126-31. PubMed ID: 25443534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
    Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Thomas G; Kiss A; Mamedov A; Deabreu A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):898-905. PubMed ID: 21237581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study.
    Zilli T; Jorcano S; Rouzaud M; Dipasquale G; Nouet P; Toscas JI; Casanova N; Wang H; Escudé L; Mollà M; Linero D; Weber DC; Miralbell R
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):382-9. PubMed ID: 20884129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer.
    Karlsdóttir A; Johannessen DC; Muren LP; Wentzel-Larsen T; Dahl O
    Radiother Oncol; 2004 Apr; 71(1):43-53. PubMed ID: 15066295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models for predicting objective function weights in prostate cancer IMRT.
    Boutilier JJ; Lee T; Craig T; Sharpe MB; Chan TC
    Med Phys; 2015 Apr; 42(4):1586-95. PubMed ID: 25832049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis.
    Jani AB; Hand CM; Pelizzari CA; Roeske JC; Krauz L; Vijayakumar S
    BMC Cancer; 2003 May; 3():16. PubMed ID: 12744725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.